Lilly's Alzheimer Drug Enters Phase III Trials - eFluxMedia
 dBTechno | Lilly's Alzheimer Drug Enters Phase III Trials eFluxMedia - By Alice Turner Eli Lilly announced that it prepares a phase III trial for its experimental drug for Alzheimer's, LY450139. The IDENTITY Trial - Interrupting Alzheimer's Dementia by EvaluatiNg Treatment of AmyloId PaThologY, is a randomized, ... Lilly Launches Phase III Trial For Treatment Of Alzheimer's Lilly trial will test drug for Alzheimer's |